MTOR and myotonic dystrophy type 1: There were no significant differences in the levels of LC3II/LC3I, p-mTOR/mTOR, PCNA, and P62 between the DM1-03+Ad-MBNL1+rapamycin and DM1-03 groups (Fig. 6a, b).